Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

75.57USD
23 Sep 2016
Change (% chg)

$-1.52 (-1.97%)
Prev Close
$77.09
Open
$77.04
Day's High
$77.78
Day's Low
$75.56
Volume
484,655
Avg. Vol
795,861
52-wk High
$110.75
52-wk Low
$49.96

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.15 December 23 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 9 9 8 8
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.93 1.93 1.92 1.92

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 11 11.07 35.00 1.50 2.50
Quarter Ending Dec-16 11 12.63 39.60 1.50 2.50
Year Ending Dec-16 13 39.21 64.90 19.10 57.55
Year Ending Dec-17 15 59.97 121.00 20.59 160.94
Earnings (per share)
Quarter Ending Sep-16 12 -1.15 -1.00 -1.35 -1.21
Quarter Ending Dec-16 12 -1.20 -0.77 -1.41 -1.27
Year Ending Dec-16 12 -4.64 -4.11 -5.02 -3.67
Year Ending Dec-17 14 -5.07 -4.03 -5.82 -2.86

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 8.09 8.71 0.62 7.64
Quarter Ending Mar-16 7.74 7.34 0.40 5.16
Quarter Ending Dec-15 9.10 7.55 1.55 17.00
Quarter Ending Sep-15 7.55 6.32 1.22 16.22
Quarter Ending Jun-15 12.64 8.69 3.95 31.29
Earnings (per share)
Quarter Ending Jun-16 -1.24 -1.05 0.19 -15.38
Quarter Ending Mar-16 -1.05 -1.21 0.16 -15.13
Quarter Ending Dec-15 -0.96 -1.07 0.11 -11.96
Quarter Ending Sep-15 -0.91 -0.91 0.00 -0.46
Quarter Ending Jun-15 -0.74 -0.85 0.11 -14.17

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 11.07 11.07 11.27 12.47 2.50
Quarter Ending Dec-16 12.63 12.63 9.93 12.31 2.50
Year Ending Dec-16 39.21 39.21 37.07 41.69 57.55
Year Ending Dec-17 59.97 59.97 59.71 57.95 160.94
Earnings (per share)
Quarter Ending Sep-16 -1.15 -1.15 -1.16 -1.24 -1.21
Quarter Ending Dec-16 -1.20 -1.20 -1.24 -1.25 -1.27
Year Ending Dec-16 -4.64 -4.64 -4.68 -4.94 -3.67
Year Ending Dec-17 -5.07 -5.07 -5.11 -5.40 -2.86

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 1
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 1 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 1 0

Analyst Research Reports

Report Title Price
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.